HIKAL
Back to All Ratios
|
HIKAL Last 5 Year Payable days History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Payable days | 127.05 | 131.02 | 92.70 | 87.68 | 86.55 |
What is the latest Payable days ratio of HIKAL ?
Year | Payable days |
---|---|
Mar2025 | 127.05 |
Mar2024 | 131.02 |
Mar2023 | 92.70 |
Mar2022 | 87.68 |
Mar2021 | 86.55 |
How is Payable days of HIKAL Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2025 | 127.05 | -3.03 | |
Mar2024 | 131.02 | 41.34 | |
Mar2023 | 92.7 | 5.73 | |
Mar2022 | 87.68 | 1.31 | |
Mar2021 | 86.55 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹2,977.1 Cr | -0% | -11.1% | -34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 1% | 9.4% | 8% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -0% |
-11.1% |
-34.2% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses